E. Grosshans and L. Marot first described blaschkitis in 1990 as a linear i
nflammatory dermatitis following lines of Blaschko in an adult patient. We
report another case which occurred in a 38-year-old woman who developed an
extensive, linear, erythematosquamous dermatitis involving the face, all li
mbs and the trunk. The patient's serum tested positive for antinuclear anti
bodies at a dilution of 1:640. The lesions regressed spontaneously within 4
weeks. Blaschkitis is a distinct entity which corresponds neither to a kno
wn inflammatory dermatitis in the lines of Blaschko nor to an hamartoma nor
to an X-linked disease. Cutaneous antigenic mosaicism,the expression of wh
ich might be induced by a viral infection, could trigger this localized inf
lammatory T-cell response. This hypothesis relates blaschkitis to other cut
aneous autoimmune diseases, as does the presence of antinuclear antibodies.
We therefore suggest renaming this type of inflammatory dermatitis Grossha
ns-Marot disease in honour to the dermatologists who first described the en
tity.